Literature DB >> 34593304

FGF/FGFR signaling: From lung development to respiratory diseases.

Lehe Yang1, Feng Zhou1, Dandan Zheng1, Dandan Wang2, Xiaokun Li3, Chengguang Zhao4, Xiaoying Huang5.   

Abstract

The fibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR) signaling system regulates a variety of biological processes, including embryogenesis, angiogenesis, wound repair, tissue homeostasis, and cancer. It exerts these regulatory functions by controlling proliferation, differentiation, migration, survival, and metabolism of target cells. The morphological structure of the lung is a complex tree-like network for effective oxygen exchange, and the airway terminates in the middle and distal ends of many alveoli. FGF/FGFR signaling plays an important role in the pathophysiology of lung development and pathogenesis of various human respiratory diseases. Here, we mainly review recent advances in FGF/FGFR signaling during human lung development and respiratory diseases, including lung cancer, acute lung injury (ALI), pulmonary arterial hypertension (PAH), chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  FGF; FGFR; Lung cancer; Lung development; Respiratory diseases

Mesh:

Substances:

Year:  2021        PMID: 34593304     DOI: 10.1016/j.cytogfr.2021.09.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  4 in total

1.  CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1.

Authors:  Ruirui Zhang; Huanyu Zhao; Hongmei Yuan; Jian Wu; Haiyan Liu; Suan Sun; Zhengwei Zhang; Jiayang Wang
Journal:  Front Genet       Date:  2021-11-25       Impact factor: 4.599

Review 2.  Targeting fibrosis, mechanisms and cilinical trials.

Authors:  Manyu Zhao; Liqun Wang; Mengzhu Wang; Shijie Zhou; Ying Lu; Huijie Cui; Alexandra C Racanelli; Ling Zhang; Tinghong Ye; Bisen Ding; Ben Zhang; Jinliang Yang; Yuqin Yao
Journal:  Signal Transduct Target Ther       Date:  2022-06-30

Review 3.  Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis.

Authors:  Hongbo Ma; Shengming Liu; Shanrui Li; Yong Xia
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

4.  Phenotypic spectrum of FGF10-related disorders: a systematic review.

Authors:  Katarzyna Bzdega; Justyna A Karolak
Journal:  PeerJ       Date:  2022-09-14       Impact factor: 3.061

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.